The purpose of this study is to determine whether a single intravenous administration of an
N-methyl-D-aspartate antagonist is safe and effective for the acute treatment of bipolar
depression.
Phase:
Phase 4
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai Murrough, James, M.D.